Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting.

Nanopore sequencing community transmission genomic epidemiology infection chain rapid sequencing

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
23 03 2022
Historique:
received: 19 04 2021
pubmed: 29 6 2021
medline: 30 3 2022
entrez: 28 6 2021
Statut: ppublish

Résumé

Tracing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveillance in an urban setting, combining a) viral surveillance sequencing, b) genetically based identification of infection clusters in the population, c) integration of public health authority contact tracing data, and d) a user-friendly dashboard application as a central data analysis platform. Application of the integrated system from August to December 2020 enabled a characterization of viral population structure, analysis of 4 outbreaks at a maximum care hospital, and genetically based identification of 5 putative population infection clusters, all of which were confirmed by contact tracing. The system contributed to the development of improved hospital infection control and prevention measures and enabled the identification of previously unrecognized transmission chains, involving a martial arts gym and establishing a link between the hospital to the local population. Integrated systems of genomic surveillance could contribute to the monitoring and, potentially, improved management of SARS-CoV-2 transmission in the population.

Sections du résumé

BACKGROUND
Tracing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing.
METHODS
In collaboration with local public health authorities, we set up an integrated system of genomic surveillance in an urban setting, combining a) viral surveillance sequencing, b) genetically based identification of infection clusters in the population, c) integration of public health authority contact tracing data, and d) a user-friendly dashboard application as a central data analysis platform.
RESULTS
Application of the integrated system from August to December 2020 enabled a characterization of viral population structure, analysis of 4 outbreaks at a maximum care hospital, and genetically based identification of 5 putative population infection clusters, all of which were confirmed by contact tracing. The system contributed to the development of improved hospital infection control and prevention measures and enabled the identification of previously unrecognized transmission chains, involving a martial arts gym and establishing a link between the hospital to the local population.
CONCLUSIONS
Integrated systems of genomic surveillance could contribute to the monitoring and, potentially, improved management of SARS-CoV-2 transmission in the population.

Identifiants

pubmed: 34181711
pii: 6310838
doi: 10.1093/cid/ciab588
pmc: PMC8406867
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1039-1046

Subventions

Organisme : Jürgen Manchot Foundation German Research Foundation
ID : 428994620
Organisme : German Federal Ministry of Education and Research
ID : 031L0184B

Investigateurs

Janine Altmüller (J)
Angel Angelov (A)
Anna C Aschenbrenner (AC)
Robert Bals (R)
Alexander Bartholomäus (A)
Anke Becker (A)
Daniela Bezdan (D)
Michael Bitzer (M)
Helmut Blum (H)
Ezio Bonifacio (E)
Peer Bork (P)
Nicolas Casadei (N)
Thomas Clavel (T)
Maria Colome-Tatche (M)
Inti Alberto De La Rosa Velázquez (IA)
Andreas Diefenbach (A)
Alexander Dilthey (A)
Nicole Fischer (N)
Konrad Förstner (K)
Sören Franzenburg (S)
Julia-Stefanie Frick (JS)
Gisela Gabernet (G)
Julien Gagneur (J)
Tina Ganzenmüller (T)
Marie Gauder (M)
Alexander Goesmann (A)
Siri Göpel (S)
Adam Grundhoff (A)
Hajo Grundmann (H)
Torsten Hain (T)
André Heimbach (A)
Michael Hummel (M)
Thomas Iftner (T)
Angelika Iftner (A)
Stefan Janssen (S)
Jörn Kalinowski (J)
René Kallies (R)
Birte Kehr (B)
Andreas Keller (A)
Oliver Keppler (O)
Sarah Kim-Hellmuth (S)
Christoph Klein (C)
Michael Knop (M)
Oliver Kohlbacher (O)
Karl Köhrer (K)
Jan Korbel (J)
Peter G Kremsner (PG)
Denise Kühnert (D)
Ingo Kurth (I)
Markus Landthaler (M)
Yang Li (Y)
Kerstin Ludwig (K)
Oliwia Makarewicz (O)
Manja Marz (M)
Alice McHardy (A)
Christian Mertes (C)
Maximilian Münchhoff (M)
Sven Nahnsen (S)
Markus Nöthen (M)
Francine Ntoumi (F)
Peter Nürnberg (P)
Uwe Ohler (U)
Stephan Ossowski (S)
Jörg Overmann (J)
Silke Peter (S)
Klaus Pfeffer (K)
Anna R Poetsch (AR)
Ulrike Protzer (U)
Alfred Pühler (A)
Nikolaus Rajewsky (N)
Markus Ralser (M)
Olaf Rieß (O)
Stephan Ripke (S)
Ulisses Rocha (U)
Philip Rosenstiel (P)
Emmanuel Saliba (E)
Leif Erik Sander (LE)
Birgit Sawitzki (B)
Simone Scheithauer (S)
Philipp Schiffer (P)
Jonathan Schmid-Burgk (J)
Wulf Schneider (W)
Eva-Christina Schulte (EC)
Joachim Schultze (J)
Alexander Sczyrba (A)
Mariam L Sharaf (ML)
Yogesh Singh (Y)
Michael Sonnabend (M)
Oliver Stegle (O)
Jens Stoye (J)
Fabian Theis (F)
Janne Vehreschild (J)
Thirumalaisamy P Velavan (TP)
Jörg Vogel (J)
Max von Kleist (M)
Andreas Walker (A)
Jörn Walter (J)
Dagmar Wieczorek (D)
Sylke Winkler (S)
John Ziebuhr (J)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Auteurs

Andreas Walker (A)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Torsten Houwaart (T)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Patrick Finzer (P)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Zotz | Klimas, Düsseldorf, Germany.

Lutz Ehlkes (L)

Düsseldorf Health Department (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.

Alona Tyshaieva (A)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Maximilian Damagnez (M)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Daniel Strelow (D)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Ashley Duplessis (A)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Jessica Nicolai (J)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Tobias Wienemann (T)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Teresa Tamayo (T)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Malte Kohns Vasconcelos (M)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Lisanna Hülse (L)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Katrin Hoffmann (K)

Zotz | Klimas, Düsseldorf, Germany.

Nadine Lübke (N)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Sandra Hauka (S)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Marcel Andree (M)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Martin P Däumer (MP)

SeqIT GmbH, Pfaffplatz 10, 67655 Kaiserslautern, Germany.

Alexander Thielen (A)

SeqIT GmbH, Pfaffplatz 10, 67655 Kaiserslautern, Germany.

Susanne Kolbe-Busch (S)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Klaus Göbels (K)

Düsseldorf Health Department (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.

Rainer Zotz (R)

Zotz | Klimas, Düsseldorf, Germany.

Klaus Pfeffer (K)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Jörg Timm (J)

Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Alexander T Dilthey (AT)

Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH